Correlation Between AN2 Therapeutics and Alterity Therapeutics
Can any of the company-specific risk be diversified away by investing in both AN2 Therapeutics and Alterity Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining AN2 Therapeutics and Alterity Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between AN2 Therapeutics and Alterity Therapeutics, you can compare the effects of market volatilities on AN2 Therapeutics and Alterity Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in AN2 Therapeutics with a short position of Alterity Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of AN2 Therapeutics and Alterity Therapeutics.
Diversification Opportunities for AN2 Therapeutics and Alterity Therapeutics
-0.24 | Correlation Coefficient |
Very good diversification
The 3 months correlation between AN2 and Alterity is -0.24. Overlapping area represents the amount of risk that can be diversified away by holding AN2 Therapeutics and Alterity Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Alterity Therapeutics and AN2 Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on AN2 Therapeutics are associated (or correlated) with Alterity Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Alterity Therapeutics has no effect on the direction of AN2 Therapeutics i.e., AN2 Therapeutics and Alterity Therapeutics go up and down completely randomly.
Pair Corralation between AN2 Therapeutics and Alterity Therapeutics
Given the investment horizon of 90 days AN2 Therapeutics is expected to generate 2.13 times more return on investment than Alterity Therapeutics. However, AN2 Therapeutics is 2.13 times more volatile than Alterity Therapeutics. It trades about 0.21 of its potential returns per unit of risk. Alterity Therapeutics is currently generating about -0.13 per unit of risk. If you would invest 110.00 in AN2 Therapeutics on August 29, 2024 and sell it today you would earn a total of 29.00 from holding AN2 Therapeutics or generate 26.36% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Insignificant |
| Accuracy | 100.0% |
| Values | Daily Returns |
AN2 Therapeutics vs. Alterity Therapeutics
Performance |
| Timeline |
| AN2 Therapeutics |
| Alterity Therapeutics |
AN2 Therapeutics and Alterity Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with AN2 Therapeutics and Alterity Therapeutics
The main advantage of trading using opposite AN2 Therapeutics and Alterity Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if AN2 Therapeutics position performs unexpectedly, Alterity Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Alterity Therapeutics will offset losses from the drop in Alterity Therapeutics' long position.| AN2 Therapeutics vs. Eliem Therapeutics | AN2 Therapeutics vs. Scpharmaceuticals | AN2 Therapeutics vs. Milestone Pharmaceuticals | AN2 Therapeutics vs. Seres Therapeutics |
| Alterity Therapeutics vs. Eliem Therapeutics | Alterity Therapeutics vs. Scpharmaceuticals | Alterity Therapeutics vs. Milestone Pharmaceuticals | Alterity Therapeutics vs. Seres Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Earnings Calls module to check upcoming earnings announcements updated hourly across public exchanges.
Other Complementary Tools
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
| Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm | |
| Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios |